TPC enters earnings season on the back foot, down nearly 10% over the past week to $74.87, with options traders turning more defensive and a track record of brutal post-earnings moves that the market has not forgotten.
The clearest shift this week is in options positioning. The put/call ratio has risen to 0.45, about 1.3 standard deviations above its 20-day average of 0.41 — the highest defensive lean in roughly a month. That's a notable jump for a name that spent most of June with a PCR in the 0.37-0.44 range. It doesn't signal outright panic, but the direction of travel is unambiguous: investors are buying more downside protection into the August 6 earnings date. The 52-week PCR range runs from 0.07 to 0.70, so current levels are elevated but not extreme — positioning looks cautious rather than crowded.
Short interest tells a far less alarming story. Bears hold roughly 4% of the free float — up about 18% on a 30-day basis in share count terms, but that cumulative build still leaves short interest well within the moderate range. Borrowing costs have actually eased, running at 0.44% annually, down 14% on the week. Availability is exceptionally loose, with nearly 40 million shares available relative to just over 2 million short — a ratio that leaves virtually no squeeze risk in the lending market. The short-score reading of 38.9 ranks in the 34th percentile of the universe, consistent with a name that shorts are monitoring but not aggressively pressing.
The Street was broadly constructive earlier this year, with UBS raising its target to $98 in early March while maintaining a Buy. That target — set more than four months ago — now sits 51% above the current price, implying meaningful implied upside if the bull case holds. Valuation multiples remain undemanding: the stock trades at roughly 14.9x trailing earnings and 9.4x EV/EBITDA, with both ratios drifting higher over the past 30 days as the share price recovered from earlier lows. The EPS surprise factor score sits in only the 22nd percentile, however, flagging a history of missing consensus — a data point that matters more than usual given what recent prints have delivered.
The earnings history is the sharpest warning in the dataset. The May 2026 print produced a one-day move of nearly -16% and a five-day move of -17%. The November-quarter print showed a similar -15% next-day drop. Two consecutive quarters of double-digit post-earnings declines establish a pattern that options traders are clearly pricing around. The Q3 report on August 6 arrives with the stock already having given back much of its April-May rally, meaning the bar for relief is arguably lower — but the repeat risk is equally visible.
Insider activity adds a layer of ambiguity. Two executive vice presidents received restricted stock awards on June 19 and promptly sold a combined 27,000 shares near $78 — the kind of tax-driven liquidation that's mechanically expected with awards. More meaningful is Director Robert Lieber's open-market sales of 27,500 shares across May 19 and May 27 at prices between $74 and $76, netting roughly $2.1 million. Those trades were discretionary, not award-linked, and carried a trade significance score of 3 — the highest in the recent window. Meanwhile, the Executive Chairman received and simultaneously sold 152,932 shares in March at $67.76. Net insider activity over 90 days is technically positive in share terms, but that reflects award grants rather than open-market buying conviction.
The week to watch is August 6: whether TPC can break the pattern of double-digit post-earnings drawdowns, and whether the Street — which has been steadily lifting targets — finally gets the operational delivery to justify the gap between the current price and consensus expectations.
See the live data behind this article on ORTEX.
Open TPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
